156 related articles for article (PubMed ID: 33917756)
1. Doxorubicin-Loaded Metal-Organic Frameworks Nanoparticles with Engineered Cyclodextrin Coatings: Insights on Drug Location by Solid State NMR Spectroscopy.
Li X; Porcino M; Qiu J; Constantin D; Martineau-Corcos C; Gref R
Nanomaterials (Basel); 2021 Apr; 11(4):. PubMed ID: 33917756
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled multifunctional core-shell highly porous metal-organic framework nanoparticles.
Qiu J; Li X; Steenkeste K; Barroca-Aubry N; Aymes-Chodur C; Roger P; Casas-Solvas JM; Vargas-Berenguel A; Rihouey C; Picton L; Gref R
Int J Pharm; 2020 May; 581():119281. PubMed ID: 32276089
[TBL] [Abstract][Full Text] [Related]
3. Porous nanoparticles with engineered shells release their drug cargo in cancer cells.
Qiu J; Li X; Rezaei M; Patriarche G; Casas-Solvas JM; Moreira-Alvarez B; Costa Fernandez JM; Encinar JR; Savina F; Picton L; Vargas-Berenguel A; Gref R
Int J Pharm; 2021 Dec; 610():121230. PubMed ID: 34718091
[TBL] [Abstract][Full Text] [Related]
4. Solid-state NMR spectroscopy as a powerful tool to investigate the location of fluorinated lipids in highly porous hybrid organic-inorganic nanoparticles.
Porcino M; Li X; Gref R; Martineau-Corcos C
Magn Reson Chem; 2021 Sep; 59(9-10):1038-1047. PubMed ID: 33709480
[TBL] [Abstract][Full Text] [Related]
5. A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.
Agostoni V; Horcajada P; Noiray M; Malanga M; Aykaç A; Jicsinszky L; Vargas-Berenguel A; Semiramoth N; Daoud-Mahammed S; Nicolas V; Martineau C; Taulelle F; Vigneron J; Etcheberry A; Serre C; Gref R
Sci Rep; 2015 Jan; 5():7925. PubMed ID: 25603994
[TBL] [Abstract][Full Text] [Related]
6. Design of Engineered Cyclodextrin Derivatives for Spontaneous Coating of Highly Porous Metal-Organic Framework Nanoparticles in Aqueous Media.
Cutrone G; Li X; Casas-Solvas JM; Menendez-Miranda M; Qiu J; Benkovics G; Constantin D; Malanga M; Moreira-Alvarez B; Costa-Fernandez JM; García-Fuentes L; Gref R; Vargas-Berenguel A
Nanomaterials (Basel); 2019 Aug; 9(8):. PubMed ID: 31374940
[TBL] [Abstract][Full Text] [Related]
7. Construction of Hyaluronic Acid-Covered Hierarchically Porous MIL-nanoMOF for Loading and Controlled Release of Doxorubicin.
Yao YR; Jin YJ; Jia X; Yang Y
Chemistry; 2021 Feb; 27(9):2987-2992. PubMed ID: 33169462
[TBL] [Abstract][Full Text] [Related]
8. A non-covalent "click chemistry" strategy to efficiently coat highly porous MOF nanoparticles with a stable polymeric shell.
Aykaç A; Noiray M; Malanga M; Agostoni V; Casas-Solvas JM; Fenyvesi É; Gref R; Vargas-Berenguel A
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1606-1616. PubMed ID: 28137620
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Metal-Organic Frameworks: Unlocking the Potential of Solid-State NMR.
Lucier BEG; Chen S; Huang Y
Acc Chem Res; 2018 Feb; 51(2):319-330. PubMed ID: 29251909
[TBL] [Abstract][Full Text] [Related]
10. Highly Efficient Encapsulation of Doxorubicin Hydrochloride in Metal-Organic Frameworks for Synergistic Chemotherapy and Chemodynamic Therapy.
Yao L; Tang Y; Cao W; Cui Y; Qian G
ACS Biomater Sci Eng; 2021 Oct; 7(10):4999-5006. PubMed ID: 34550683
[TBL] [Abstract][Full Text] [Related]
11. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
Li J; Zhang Z; Li J; Cun JE; Pan Q; Gao W; Luo K; He B; Gu Z; Pu Y
Acta Biomater; 2022 Oct; 152():495-506. PubMed ID: 36087871
[TBL] [Abstract][Full Text] [Related]
12. New insights on the supramolecular structure of highly porous core-shell drug nanocarriers using solid-state NMR spectroscopy.
Porcino M; Christodoulou I; Vuong MDL; Gref R; Martineau-Corcos C
RSC Adv; 2019 Oct; 9(56):32472-32475. PubMed ID: 35529756
[TBL] [Abstract][Full Text] [Related]
13. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
14. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin.
Karimi S; Namazi H
Int J Pharm; 2023 Mar; 634():122675. PubMed ID: 36736967
[TBL] [Abstract][Full Text] [Related]
17. Identifying Differing Intracellular Cargo Release Mechanisms by Monitoring
Markopoulou P; Panagiotou N; Li A; Bueno-Perez R; Madden D; Buchanan S; Fairen-Jimenez D; Shiels PG; Forgan RS
Cell Rep Phys Sci; 2020 Nov; 1(11):100254. PubMed ID: 33244524
[TBL] [Abstract][Full Text] [Related]
18. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
19. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
